Is Dev Labtech overvalued or undervalued?

As of 24 October 2025, the valuation grade for Dev Labtech has moved from fair to expensive, indicating a shift in perception regarding its market value. The company is currently deemed overvalued based on its high PE ratio of 56.15 and an EV to EBITDA ratio of 23.92, which are significantly higher than some of its peers. For instance, Titan Company has a PE ratio of 88.77, while Kalyan Jewellers stands at 63.81, both of which are also classified as expensive but still reflect a more favorable valuation compared to Dev Labtech. The company's financial metrics further reinforce this overvaluation stance, with a ROCE of only 4.75% and a ROE of 3.20%, suggesting that the returns generated on capital and equity are relatively low. Additionally, the stock has underperformed compared to the Sensex, with a year-to-date return of -20.7% versus the Sensex's 7.77%, highlighting the market's lack of confidence in its growth prospects. Overall, Dev Labtech appears to be overvalued in the current market environment.